Evaluating the effect of dry cupping, and Aslaq capsule, on the infertility
Phase 3
Recruiting
- Conditions
- Infertility due to polycystic ovary syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20180923041093N7
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
PCOs based on Rotterdam criteria and diagnosing infertility fellowship
Infertility with at least one year of unprotected intercourse
Age between 18 and 35 years
Exclusion Criteria
Systemic disease requires serious therapeutic interventions
premature ovarian failure
Single ovarian cyst or breast cyst
Endometriosis, Pelvic Adhesions, Tube Obstruction, Tube Abnormalities, and Hyperprolactinemia
Infertility due to male factor
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of pregnancy occurrence. Timepoint: After the intervention. Method of measurement: sonography or BHCG.
- Secondary Outcome Measures
Name Time Method Menstrual pain. Timepoint: Monthly. Method of measurement: Visual analogue scale.;The length of the menstrual cycle. Timepoint: Monthly. Method of measurement: Time interval from the first day of menstrual bleeding to the last day of menstrual bleeding in a cycle. Based on the person's response to the questionnaire.;Ovulation rate. Timepoint: Monthly. Method of measurement: Ultrasonography.;Endometrial thickness. Timepoint: Monthly - Day 13 of the menstrual cycle. Method of measurement: Ultrasonography.;Follicle growth. Timepoint: Monthly - Day 13 of the menstrual cycle. Method of measurement: Ultrasonography.;Sexual function. Timepoint: At the beginning of the intervention, three and six months after the start of the intervention. Method of measurement: Female sexual function index.